223 related articles for article (PubMed ID: 24039897)
1. A Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cells.
Yin J; Zheng G; Jia X; Zhang Z; Zhang W; Song Y; Xiong Y; He Z
PLoS One; 2013; 8(9):e73268. PubMed ID: 24039897
[TBL] [Abstract][Full Text] [Related]
2. A miR-200c/141-BMI1 autoregulatory loop regulates oncogenic activity of BMI1 in cancer cells.
Dimri M; Kang M; Dimri GP
Oncotarget; 2016 Jun; 7(24):36220-36234. PubMed ID: 27105531
[TBL] [Abstract][Full Text] [Related]
3. Timosaponin A-III inhibits oncogenic phenotype via regulation of PcG protein BMI1 in breast cancer cells.
Gergely JE; Dorsey AE; Dimri GP; Dimri M
Mol Carcinog; 2018 Jul; 57(7):831-841. PubMed ID: 29528145
[TBL] [Abstract][Full Text] [Related]
4. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1.
Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP
Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816
[TBL] [Abstract][Full Text] [Related]
5. The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer.
Heydari K; Saidijam M; Sharifi MR; Dermani FK; Soleimani Asl S; Shabab N; Najafi R
Pathol Oncol Res; 2018 Jan; 24(1):145-151. PubMed ID: 28411308
[TBL] [Abstract][Full Text] [Related]
6. Anticancer effects of miR-200c in colorectal cancer through BMI1.
Karimi Mazraehshah M; Tavangar SM; Saidijam M; Amini R; Bahreini F; Karimi Dermani F; Najafi R
J Cell Biochem; 2018 Dec; 119(12):10005-10012. PubMed ID: 30171714
[TBL] [Abstract][Full Text] [Related]
7. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
[TBL] [Abstract][Full Text] [Related]
8. Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog.
Paranjape AN; Balaji SA; Mandal T; Krushik EV; Nagaraj P; Mukherjee G; Rangarajan A
BMC Cancer; 2014 Oct; 14():785. PubMed ID: 25348805
[TBL] [Abstract][Full Text] [Related]
9. miR-200c/Bmi1 axis and epithelial-mesenchymal transition contribute to acquired resistance to BRAF inhibitor treatment.
Liu S; Tetzlaff MT; Wang T; Yang R; Xie L; Zhang G; Krepler C; Xiao M; Beqiri M; Xu W; Karakousis G; Schuchter L; Amaravadi RK; Xu W; Wei Z; Herlyn M; Yao Y; Zhang L; Wang Y; Zhang L; Xu X
Pigment Cell Melanoma Res; 2015 Jul; 28(4):431-41. PubMed ID: 25903073
[TBL] [Abstract][Full Text] [Related]
10. Bmi1 gene silencing inhibits the proliferation and invasiveness of human hepatocellular carcinoma cells and increases their sensitivity to 5-fluorouracil.
Zhang R; Xu LB; Yue XJ; Yu XH; Wang J; Liu C
Oncol Rep; 2013 Mar; 29(3):967-74. PubMed ID: 23242307
[TBL] [Abstract][Full Text] [Related]
11. Mir-1307 regulates cisplatin resistance by targeting Mdm4 in breast cancer expressing wild type P53.
Wang X; Zhu J
Thorac Cancer; 2018 Jun; 9(6):676-683. PubMed ID: 29697201
[TBL] [Abstract][Full Text] [Related]
12. miR-200c suppresses stemness and increases cellular sensitivity to trastuzumab in HER2+ breast cancer.
Tang H; Song C; Ye F; Gao G; Ou X; Zhang L; Xie X; Xie X
J Cell Mol Med; 2019 Dec; 23(12):8114-8127. PubMed ID: 31599500
[TBL] [Abstract][Full Text] [Related]
13. Regulating BMI1 expression via miRNAs promote Mesenchymal to Epithelial Transition (MET) and sensitizes breast cancer cell to chemotherapeutic drug.
Patel N; Garikapati KR; Makani VKK; Nair AD; Vangara N; Bhadra U; Pal Bhadra M
PLoS One; 2018; 13(2):e0190245. PubMed ID: 29394261
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MALAT1 Functions as a Competing Endogenous RNA to Regulate BMI1 Expression by Sponging miR-200c/miR-203 in the Control of the Differentiation of Pulp Cells.
Jin H; Zhao J; Li C
Biochem Genet; 2021 Oct; 59(5):1260-1277. PubMed ID: 33772374
[TBL] [Abstract][Full Text] [Related]
15. Fas signaling induces stemness properties in colorectal cancer by regulation of Bmi1.
Chen J; Wang Y; Zhuo L; Liu Z; Liu T; Li W; Cai Y; Zheng H
Mol Carcinog; 2017 Oct; 56(10):2267-2278. PubMed ID: 28543447
[TBL] [Abstract][Full Text] [Related]
16. PLK1 inhibition down-regulates polycomb group protein BMI1 via modulation of the miR-200c/141 cluster.
Dimri M; Cho JH; Kang M; Dimri GP
J Biol Chem; 2015 Jan; 290(5):3033-44. PubMed ID: 25505268
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of BMI1-suppressor miRNAs (miR-200c, miR-203) during terminal differentiation of colon epithelial cells.
Hisamori S; Mukohyama J; Koul S; Hayashi T; Rothenberg ME; Maeda M; Isobe T; Valencia Salazar LE; Qian X; Johnston DM; Qian D; Lao K; Asai N; Kakeji Y; Gennarino VA; Sahoo D; Dalerba P; Shimono Y
J Gastroenterol; 2022 Jun; 57(6):407-422. PubMed ID: 35244768
[TBL] [Abstract][Full Text] [Related]
18. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
19. miR-200c sensitizes breast cancer cells to doxorubicin treatment by decreasing TrkB and Bmi1 expression.
Kopp F; Oak PS; Wagner E; Roidl A
PLoS One; 2012; 7(11):e50469. PubMed ID: 23209748
[TBL] [Abstract][Full Text] [Related]
20. MiR-200c inhibits autophagy and enhances radiosensitivity in breast cancer cells by targeting UBQLN1.
Sun Q; Liu T; Yuan Y; Guo Z; Xie G; Du S; Lin X; Xu Z; Liu M; Wang W; Yuan Q; Chen L
Int J Cancer; 2015 Mar; 136(5):1003-12. PubMed ID: 25044403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]